Noninvasive Ventilation and Exogenous Surfactant in Times of Ever Decreasing Gestational Age: How Do We Make the Most of These Tools?

Clyde J Wright; Kirsten Glaser; Christian P Speer; Christoph Härtel; Charles C Roehr

doi:10.1016/j.jpeds.2022.04.011

Noninvasive Ventilation and Exogenous Surfactant in Times of Ever Decreasing Gestational Age: How Do We Make the Most of These Tools?

J Pediatr. 2022 Aug:247:138-146. doi: 10.1016/j.jpeds.2022.04.011. Epub 2022 Apr 13.

Authors

Clyde J Wright¹, Kirsten Glaser², Christian P Speer³, Christoph Härtel³, Charles C Roehr⁴

Affiliations

¹ Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.
² Division of Neonatology, Department of Women's and Children's Health, University of Leipzig Medical Center, Leipzig, Germany.
³ Department of Pediatrics, University Hospital of Würzburg, Würzburg, Germany.
⁴ Southmead Hospital, North Bristol NHS Trust, University of Bristol, Dept. Pediatrics, Faculty of Health Science, Bristol, UK; National Perinatal Epidemiology Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford Oxfordshire, UK. Electronic address: [email protected].

PMID: 35429507
DOI: 10.1016/j.jpeds.2022.04.011

No abstract available

Keywords: bronchopulmonary dysplasia (BPD); continuous positive airway pressure (CPAP); exogenous surfactant therapy; extreme prematurity; noninvasive respiratory support; preterm infant; respiratory distress syndrome (RDS).

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Bronchopulmonary Dysplasia*
Continuous Positive Airway Pressure
Gestational Age
Humans
Infant, Newborn
Noninvasive Ventilation*
Pulmonary Surfactants* / therapeutic use
Respiration, Artificial
Respiratory Distress Syndrome, Newborn* / drug therapy
Surface-Active Agents / therapeutic use

Substances

Pulmonary Surfactants
Surface-Active Agents

Grants and funding

R01 HL132941/HL/NHLBI NIH HHS/United States